Entod introduces new probiotic for treating nasal allergies

Entod Pharmaceuticals has introduced a new probiotic to help manage nasal allergies. Probiotics are known for promoting a healthy gut and boosting overall immunity, but now their role in reducing allergic reactions in the nose has been confirmed through clinical studies. The probiotic named Lactoshield RH is a blend of specific probiotic strains that have been proven to alleviate nasal allergies, especially in conditions like allergic rhinitis. It is recommended to consult an ENT specialist or rhinologist before using this probiotic.

Nikkhil K Masurkar, CEO of ENTOD Pharmaceuticals, emphasized the importance of maintaining a balanced intestinal flora to regulate inflammation and immune responses related to allergic rhinitis. Studies have shown that an unhealthy gut flora can trigger nasal allergies, and the specific strains of lactic acid bacteria in Lactoshield RH aim to stabilize the intestinal microflora, improve biodiversity, and ultimately control allergic reactions in the nose.

Product Manager, Manas Prabhudesai, highlighted that probiotic strains like those in Lactoshield RH can improve the quality of life for individuals with allergic rhinitis, reducing symptoms in both the nose and eyes. These probiotics may also have a preventative effect when taken early in treatment, especially for children.

Overall, the introduction of Lactoshield RH by Entod Pharmaceuticals offers a promising solution for those struggling with nasal allergies, backed by scientific research and clinical trials. Consultation with a healthcare professional is advised to determine the best course of action for managing allergic rhinitis.